ARTICLE

FindCenter AddIcon

The Whole Planet View

By Rosalind Watts, Sam Gandy, Alex Evans — 2019

Psychedelics offer a sense of expansive connectedness, just like astronauts have felt looking back to Earth from space.

Read on aeon.co

FindCenter Post-Image

Psilocybin Therapy May Work as Well as Common Antidepressant

The first randomized controlled trial to compare the illicit psychedelic psilocybin with a conventional selective serotonin reuptake inhibitor (SSRI) antidepressant found that the former improved symptoms of depression just as well on an established metric—and had fewer side effects.

FindCenter AddIcon
FindCenter Post-Image

Experimental Treatments Changed the Course of the AIDS Epidemic; We Need the Same Approach to Mental Illness Today | Commentary

Demand from patients seeking help for their mental illnesses has led to underground use in a way that parallels black markets in the AIDS pandemic. This underground use has been most perilous for people of color, who face greater stigma and legal risks due to the War on Drugs.

FindCenter AddIcon
FindCenter Post-Image

Study Finds Ketamine Can Help Patients Manage Depression and PTSD

Through this treatment plan, the patient was able to “reconceptualize her trauma” and “was able to move through difficult memories and emotions rather than letting them consume her,” explained U of O associate professor, Monnica Williams.

FindCenter AddIcon
FindCenter Post-Image

Introducing Ayahuasca

Amazonian healing traditions collide with Western medical sensibilities.

FindCenter AddIcon
FindCenter Post-Image

Can Ketamine Treat Depression? the Answer May Lie in a Mysterious Brain Cell

To treat depression, the neurons which control the hormones serotonin and dopamine in our brains seem to get all the attention.

FindCenter AddIcon
FindCenter Post-Image

Are Psychedelics the Answer to Depression and Addiction?

A new generation of research into psilocybin could change how we treat numerous mental health conditions.

FindCenter AddIcon
FindCenter Post-Image

Scientists Gave Depressed Patients Psilocybin in a First for Psychedelic Therapy

In a recent UK trial, 12 patients with major depression took a pill quite different to commonly prescribed antidepressants: 25mg of psilocybin, the psychedelic compound found in magic mushrooms.

FindCenter AddIcon
FindCenter Post-Image

We Can No Longer Ignore the Potential of Psychedelic Drugs to Treat Depression

At Imperial College we’ve been comparing psilocybin to conventional antidepressants—and the results are likely to be game-changing.

FindCenter AddIcon
FindCenter Post-Image

Coping with Depression and Disability

Often, disabled people have their disability treated, but they don’t have their emotional or spiritual needs addressed.

FindCenter AddIcon
FindCenter Post-Image

When a Physical Disability Keeps You from Getting Mental Health Help

Depression and suicidal ideation are more likely among people with disabilities due to factors like abuse, isolation, and stressors related to poverty, among others.

FindCenter AddIcon

EXPLORE TOPIC

Connection